1. Pitman D. Public Citizen’s Wolfe still needling FDA. MedPageToday. 14 June 2013. www.medpagetoday.com/washington-watch/washington-watch/39864
2. Wolfe SM . Letter demonstrating that rosuvastatin (Crestor) has higher rates of rhabdomyolysis compared to other statins. Public Citiz 2005. www.citizen.org/article/letter-demonstrating-that-rosuvastatin-crestor-has-higher-rates-of-rhabdomyolysis-compared-to-other-statins.
3. Rosuvastatin for lowering lipids
4. Wolfe SM Oshel RE . Ranking of the rate of state medical boards’ serious disciplinary actions, 2019-2021. Public Citiz 2023. www.citizen.org/article/report-ranking-of-the-rate-of-state-medical-boards-serious-disciplinary-actions-2019-2021.